Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1456 of 5804
-
Scientists investigate mpox in severely weakened immune systems
Knowledge-focused TerminatedThe purpose of this study is to examine the extent of mpox viral spread and immunologic markers in people with advanced HIV. Study findings will enhance knowledge of mpox pathogenesis in severely immunocompromised people, which can inform treatment and prevention of severe illnes…
Sponsor: Centers for Disease Control and Prevention • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New arthritis drug for kids shows promise in early trial
Disease control Recruiting nowThe primary objective of this study is to evaluate the pharmacokinetics (PK) of olokizumab (OKZ) in patients with polyarticular juvenile idiopathic arthritis aged \>2 and \<18 years in two doses (64 mg or 48 mg every 4 weeks) depending on patient's weight. Secondary objectives ar…
Phase: PHASE2 • Sponsor: R-Pharm International, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Can Eye-Tracking reveal hidden brain risks in babies with sickle cell disease?
Knowledge-focused CompletedEvidence indicates that Sickle Cell Disease (SCD) threatens neurodevelopmental outcome. Although children with SCD may be heterogeneously affected, neurocognitive impairment may already be present in toddlers. Neurocognitive functioning is an important determinant of adaptive dai…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
New inhaled drug aims to help COPD patients walk farther
Disease control OngoingResearchers are looking for ways to treat pulmonary hypertension (PH) caused by chronic obstructive pulmonary disease (COPD). The goal of the study is to learn if people who take frespaciguat can walk farther in 6 minutes at Week 24 compared to people who take placebo.
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New pill shows promise for ulcerative colitis in early trial
Disease control CompletedUlcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). This study will assess how safe and effective ABBV-668 is in treating adult participants with UC. Adverse events and ch…
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New shot targets genetic form of fatty liver disease
Disease control CompletedA Study to Evaluate the Efficacy, Safety and Tolerability of AZD2693 given by subcutaneous injection in adult participants with non-cirrhotic non-alcoholic steatohepatitis with fibrosis and who are carriers of the PNPLA3 148M Risk Allele
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Stroke recovery gets a boost: Brain-Device combo tracked in 1,000 patients
Disease control Recruiting nowThe purpose of the Vivistim Registry for Paired VNS Therapy (GRASP) is to gather real-world information on patients with arm and hand deficits post-stroke who are considering Vivistim System treatment. Before and after Vivistim System implant, patient data will be collected and r…
Sponsor: MicroTransponder Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug combo targets rare gynecologic cancer in phase 2 trial
Disease control Recruiting nowThis study will test if Avutometinib (VS-6766) in combination with Defactinib is an effective treatment for advanced or recurrent mesonephric gynecologic cancer.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New hope for advanced tumors: experimental drug JSKN003 enters human trials
Disease control OngoingThis is an open, multicenter study of phase I/II in Chinese subjects with unresectable locally advanced/metastatic solid tumors. It is divided into the dose escalation period and the cohort expansion period. A total of 8 dose groups (Q3W on the first day of intravenous administra…
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could buspirone and lofexidine take the edge off opioid withdrawal?
Symptom relief Recruiting nowThe investigators propose a rigorous, Phase II, three-group, placebo-controlled double-blind randomized controlled trial (RCT) to evaluate the efficacy of buspirone for both withdrawal and craving among individuals with opioid use disorder (OUD) undergoing a standardized stepwise…
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Shingles nerve block shows promise in preventing chronic pain
Disease control CompletedBackground: Acute herpes zoster causes severe neuropathic pain and may progress to postherpetic neuralgia (PHN). This study aims to evaluate ultrasound-guided thoracic paravertebral block with local anesthetic and steroid in reducing acute pain and PHN incidence. Methods: This p…
Phase: PHASE3 • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Eye movement therapy eases PTSD symptoms in jordan study
Symptom relief CompletedHere is a plain-language, registry-appropriate Brief Summary you can paste into the form. It is written for patients, families, and healthcare providers: Brief Summary This study examines whether Eye Movement Desensitization and Reprocessing (EMDR) therapy can reduce the severi…
Phase: NA • Sponsor: Al-Quds University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Diet and exercise combo shows promise for muscle loss and obesity in seniors
Disease control OngoingSarcopenic obesity (SO) has synergistic detrimental effects on elderlies' health. It greatly increases the risk of cardio-metabolic diseases, physical impairment, institutionalization, and mortality when compared with sarcopenia or obesity alone. Effective interventions to simult…
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Balloon catheters may improve stroke clot removal
Disease control CompletedThe BEST study is an academically initiated, single-center, prospective, randomized controlled clinical trial investigating the potential advantages and disadvantages of using a guide catheter with or without a balloon in the interventional treatment of acute ischemic stroke. Th…
Phase: NA • Sponsor: University Hospital Heidelberg • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New study aims to cut side effects in throat cancer treatment
Disease control Recruiting nowThis is a prospective, phase II, stratified single arm investigation for favorable prognosis in p16+ oropharynx cancer patients with either node negative or malignant neck adenopathy with lymphoscintigraphy mapping confined to the ipsilateral neck.
Phase: PHASE2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a gentler cholesterol combo prevent diabetes in heart patients?
Disease control ENROLLING_BY_INVITATIONThis study is to evaluating the impact of low-intensity statin plus ezetimibe versus high-intensity statin therapy on risk of new-onset diabetes mellitus in patients with atherosclerotic cardiovascular disease who have prediabetes.
Phase: PHASE4 • Sponsor: Seung-Whan Lee, M.D., Ph.D. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Texting your way to staying smoke-free: hong kong study tests WhatsApp relapse prevention
Prevention CompletedMost smokers return to smoking (relapse) after making a quit attempt, but evidence of effective intervention to prevent relapse is scarce. Taking advantage of recent advances in mobile technologies, this study aims to evaluate the effectiveness of a mobile chat messaging-based re…
Phase: NA • Sponsor: The University of Hong Kong • Aim: Prevention
Last updated Jun 27, 2026 07:58 UTC
-
Can Vitamin-Like supplements save sight in glaucoma?
Disease control OngoingThe objective of this study is to determine if a combination of oral nicotinamide and pyruvate (N\&P) can maintain eye health as compared to placebo while standard-of-care intraocular pressure-lowering glaucoma medications are used to treat glaucoma. A total of up to 188 partici…
Phase: PHASE2, PHASE3 • Sponsor: Columbia University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Can shingrix shield HIV patients from shingles?
⭐️ VACCINE ⭐️ Recruiting nowBackground: Shingles is a painful, blistering rash caused by the same virus that causes chickenpox. Shingrix is a vaccine approved to prevent shingles in healthy adults over age 50 and in immunocompromised adults over age 18. Researchers want to learn more about how people with …
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 16, 2026 00:00 UTC
-
Family-Focused telehealth program aims to curb alcohol abuse in veterans
Disease control Recruiting nowImproving alcohol use disorder (AUD) treatment among Veterans is a national public health problem. The rate of AUD among Veterans is twice that of civilians, with up to 50% of Veterans having AUD. Family-based AUD programs are rarely undertaken in busy treatment clinics, and Vete…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC